Table 4.
China | Netherlands | UK | USA | India | Brazil | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|
N | Keywords | N | Keywords | N | Keywords | N | Keywords | N | Keywords | N | Keywords |
93 | leprosy | 72 | leprosy | 138 | leprosy | 183 | mycobacterium leprae | 117 | leprosy | 179 | mycobacterium leprae |
35 | mycobacterium leprae | 68 | mycobacterium leprae | 102 | mycobacterium leprae | 151 | leprosy | 84 | mycobacterium leprae | 144 | disease |
22 | association | 48 | contact | 83 | tuberculosis | 58 | tuberculosis | 33 | lepromatous leprosy | 66 | diagnosis |
21 | identification | 41 | diagnosis | 60 | infection | 57 | diagnosis | 33 | disease | 55 | infection |
21 | diagnosis | 35 | risk factor | 43 | disease | 53 | infection | 32 | diagnosis | 51 | risk factor |
20 | susceptibility | 33 | tuberculosis | 32 | identification | 52 | disease | 22 | tuberculosis | 47 | lepromatous leprosy |
19 | disease | 29 | infection | 31 | mycobacterium tuberculosis | 40 | identification | 21 | expression | 48 | leprosy |
18 | tuberculosis | 28 | disease | 28 | diagnosis | 35 | contact | 20 | erythema nodosum leprosum | 43 | susceptibility |
16 | gene | 27 | Bangladesh | 26 | risk factor | 32 | lepromatous leprosy | 19 | multidrug therapy | 42 | association |
14 | variants | 25 | chemoprophylaxi | 23 | lepromatous leprosy | 31 | antigen | 18 | childhood leprosy | 41 | expression |